Stroke trial doubles disability-free recovery

The trial, which was stopped early because of its success, found 71% of patients achieved functional independence at three months post-operation under the new regime compared to 40% receiving standard care of intravenous alteplase within 4.5 hours of stroke onset.

In the trial of 70 patients, the intervention group received alteplase then underwent endovascular thrombectomy with a new stent device (Solitaire FR, Covidien).

But importantly, researchers say, CT perfusion imaging was used to identify potentially salvageable brain tissue with those patients having large ischaemic cores being excluded.

“Key